Authors
SVP, Mergers & Acquisitions, Strategic Innovation
MJH Life Sciences
Alan Balch, PhD, is CEO and incoming executive chairman, board of directors, Patient Advocate Foundation.
Richard Payerchin is editor of Medical Economics.
Director of Project Services & Logistics at Almac Pharma Services.
During his decade-long tenure at SNOW, Matthew Froestad has gathered insights into a wide cross-section of the life science industry and become a resource for anyone interested to know more about the oncology landscape. He can be reached at [email protected]
CEO of Healthark Insights.
Latest Article
The Changing Role of Access Leaders
Chief Technology Officer at Intelliguard
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How the US Section 301 Probe Targets Germany's Drug Pricing
2
Why Packaging Is Now a Frontline Issue In Pharma Supply Chains
3
Report: GLP-1s, Oncology to Drive Drug Spending Surge in 2027
4
Philip Sclafani: Will PBM Reform Actually Lower Net Drug Costs?
5

